The efficiency of endothelin receptor antagonist bosentan for pulmonary arterial hypertension associated with congenital heart disease: A systematic review and meta-analysis

Lignende værker

• Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease
  af: Apostolopoulou, S C, et al.
  Udgivet: (2005)
• The safety of endothelin receptor antagonists in the treatment of pulmonary arterial hypertension: Protocol for a systemic review and network meta-analysis
  af: Gu, Zhi-Chun, et al.
  Udgivet: (2018)
• Treatment of digital ulcers in systemtic sclerosis with endothelin-1 receptor antagonist (bosentan)
  af: V. Grattagliano, et al.
  Udgivet: (2011-09-01)
• Bosentan, a dual endothelin receptor antagonist, activates the pregnane X nuclear receptor
  af: Van Giersbergen, P L M, et al.
  Udgivet: (2002)
• Potent anti-inflammatory and antinociceptive activity of the endothelin receptor antagonist bosentan in monoarthritic mice
  af: Imhof, Anne-Katja, et al.
  Udgivet: (2011)